SEC Form 4 · accession 0001437749-26-030729
Clene Inc. · CLNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Dee Etherington
Officer — President & CEO · Director
Period of report
Sep 16, 2026
Accepted (ET)
Sep 18, 2026 · 1:41 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001822791
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stockF1 | Sep 16, 2026 | A | 15,244 | $3.28 | A | 55,393 | D | |
| common stockF2 | holding | — | — | — | 636 | I | By LLC | |
| common stockF3 | holding | — | — | — | 1,250 | I | By trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Etherington purchased 15,244 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended.
- F2The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may be deemed to be beneficially owned by Mr. Etherington.
- F3The securities are owned by the Etherington Revocable Trust. Mr. Etherington is the co-trustee of the Etherington Revocable Trust. The shares owned by the Etherington Revocable Trust may be deemed to be owned by Mr. Etherington.